期刊文献+

顺尔宁治疗儿童哮喘疗效观察及护理 被引量:2

The curative effect observation and nursing of the white three alkene acceptor antagonist in child asthma
下载PDF
导出
摘要 目的:探讨白三烯受体拮抗剂—顺尔宁治疗儿童哮喘的疗效及护理。方法:对80例儿童哮喘患儿随机分为治疗组及对照组,治疗组在对照组的基础上加用顺尔宁,治疗过程中严密观察患者的症状、不良反应、呼气流量峰值占预计值的百分比(PEF%)及复发率。结果:治疗组症状缓解及肺部体征消失时间明显缩短,复发率低于对照组,PEF%1d、3d和5d均较对照组增高,20d时两组无显著性差异。结论:顺尔宁在治疗儿童哮喘中疗效确切、依从性好、服用方便、副作用少,减少复发,可替代预防性激素吸入。 Objective: To discusses the curative effect observation and nursing of the white three alkene acceptor antagonist - Montelukast in treating the child asthma. Methods: 80 asthmatic children were randomly assigned to the observed group and the control group the treatment group adds Montelukast in basis on the control groups, in the course of treatment observing patient's symptom side effects PEF% and the recurrence rate strictly. Results: The symptom alleviation and the lungs symptom vanishing time reduces obviously in treatment group, the recurrence rate is lower than the control group, the PEF% in 1 d, 5 d and 5 d all increasing in compared with the control group, in 20d two groups having non-significance difference. Conclusions In treating the child asthma with Montelukast the curative effect is rather accurate, the compliance good, taking onveniently, the side effect few, reducing the recurrence, in place of the inhaled corticosteroids maybe.
机构地区 黑龙江省医院
出处 《中国医学装备》 2008年第4期47-50,共4页 China Medical Equipment
关键词 白三烯受体拮抗剂 儿童哮喘 顺尔宁 Asthmatic children, Leukotriene receptor antagonist, Montelukast
  • 相关文献

参考文献11

  • 1赵彩霞.顺尔宁治疗小儿哮喘疗效观察[J].现代医药卫生,2005,21(4):431-431. 被引量:24
  • 2儿童哮喘防治常规(试行)[J].中华儿科杂志,1998,36(12):747-751. 被引量:2372
  • 3[3]Back M.Functional characteristics of cysteinyl-leukotriene receptom subtypes[J].Life SCI,2002,71(5):611-622.
  • 4[4]Holroyde MC,Altounyan RE,Colem M,etal.Selective inhibition of bronchoconstriction induced by leukotfienes C and D in man[J].Adv Prostaglandin Thromboxane Leukot Res,1982,9:237-242.
  • 5[5]Mitsunobu F,Mifune T,Hasaki Y.et al.Enhanced peripheral leukocyte leukotriene production and bronchial hyperrespensiveness in asthmatics[J].Eur Respir J,2000,16:504-508.
  • 6[6]Eum SY,Maghni K,Hamid Q,et al.Involvement of the Cystoinylleukotrienes in Allergen-Induced Airway Eosinophilia and Hyperrespensiveness in the Mouse[J].Am J Respir Cell Mol Biol.2003,28:25-32.
  • 7[7]Panettieri RA,Tan EM,Ciocca V,et al.Effects of LTD4 on human airway smooth muscle cell proliferation,matrix expression,and contraction In vitro:differential sensitivity to cysteinyl leukotriene receptor antagonists[J].Am J Respir Cell Mol Biol,1998,19:453-461.
  • 8[8]Green SA,Malice MP,Tanaka W.et al.Increase in urinary leukotriene E4 levels in acute asthma correlation with airflow limitation[J].Thorax,2004,59:100-104.
  • 9[9]Dimova-Yaneva D,Russell D,Main M,et al.Eosinphil activation and cysteinyl leukotriene production in infants with respiratory syncytial virus bmnchiolitis[J].Clin Exp Allegy,2004,34:555-558.
  • 10[10]Mitsuta K,Shimeda T,Fukushima C,et al.Preoperative steroid therapy inhibits cytokine production in the lung parenchyma in asthmatic patients[J].Chest,2001,120:1175-1183.

二级参考文献12

  • 1马永录,蒋坤,任耘.白三烯受体拮抗剂治疗哮喘的进展和临床评价[J].中国医院用药评价与分析,2004,4(5):273-276. 被引量:6
  • 2Kontogiorgis CA,Hadjipavlour-Litina-DJ.Non steroidal anti-inflammatory and anti-allergy ageuts[J].Curr Med Chem,2002,9(1):89-98.
  • 3Evans D,Mellins R,Lobach K,et al.Improring care for minoritory children with asthma:professionai education in public health clinics[J].Pediatrics,1997,99(2):157-164.
  • 4Back M.Functional characteristics of cysteinyl-leukotriene receptor subtypes[J].Life SCI,2002,71(5):611-622.
  • 5Holroyde MC,Altounyan RE,Colem M,et al.Selective inhibition of bronchoconstriction induced by leukotrienes C and D in man[J].Adv Prostaglandin Thromboxane Leukot Res,1982,9:237-242.
  • 6Salvi SS,Krishna MT,Sampson AP,et al.The anti-inflammatory effects of leukotriene modifying drags and their use in asthma[J].Chest,2001,119(5):1533-1546.
  • 7Spector SL,Smith LT,Glass M.Effects of 6 weeks of therapy with oral doses of ICI 204,219,a leukotriene D4 receptor antagonist,in subjects with bronchial asthma.A CCOLATE Asthma Trialists Group[J].Am J Respir Crit Care Med,1994,150(3):618-623.
  • 8Pefers SP.Leukotriene receptor antagonist in asthma therapy[J].Allergy Clin Immunol,2003,111 (Suppl):62-70.
  • 9Chung KF,Barnes PJ.Zafirrlukast (Accolate)[J].Brugs Today (Barc),1998,34(4):375-388.
  • 10Henderson WR Jr.Tang LO,Che SJ,et al.A role for cyste leukotrienes in airway remodeling in a mouse asthma model[J].Am J Respire Crit Care Med,2002,165(8):108-116.

共引文献2387

同被引文献29

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部